Yonggang Dai, Ye Liu, Yunjun Yan, Haoran Ji, Hongya Wang, Xuewei Zhuang
{"title":"Multi-omics analysis reveals MICB promotes cerebral atherosclerosis through FTMT suppression in NK and plasma cells.","authors":"Yonggang Dai, Ye Liu, Yunjun Yan, Haoran Ji, Hongya Wang, Xuewei Zhuang","doi":"10.1186/s13148-026-02212-y","DOIUrl":"10.1186/s13148-026-02212-y","url":null,"abstract":"<p><strong>Background: </strong>Ferroptosis, an iron-dependent form of regulated cell death, is implicated in vascular injury, but how immune-related proteins modulate ferroptosis and cerebral atherosclerosis (CeA) remains unclear.</p><p><strong>Methods: </strong>We performed multi-step Mendelian randomization (MR) integrating plasma proteomics, single-cell eQTL, and FinnGen CeA GWAS data. Mediation MR quantified the role of the ferroptosis regulator FTMT. Cell-type-specific MR was conducted across 14 immune subtypes. Functional enrichment and RT-qPCR of clinical blood samples validated findings.</p><p><strong>Results: </strong>Four immune proteins (KIR2DL3, HLA-E, LTA, MICB) were identified as causal risk factors for CeA, acting primarily by downregulating FTMT (all β<sub>1</sub> < 0, P < 0.001). Mediation analysis revealed FTMT explained up to 53% of the immune protein effect. Single-cell MR demonstrated striking cell-type specificity for MICB: higher MICB in NK cells and IgJ<sup>+</sup> B cells was strongly associated with CeA risk (e.g., β = 0.90, P = 4.3 × 10<sup>-6</sup>), while higher MICB in dendritic cells was protective (β = - 0.57, P = 2.1 × 10<sup>-30</sup>). In clinical samples, RT-qPCR confirmed reduced FTMT expression, and plasma ELISA showed elevated circulating LTA, soluble MICB, and soluble HLA-E in CeA patients. Network analysis highlighted NK cell cytotoxicity as a central pathway.</p><p><strong>Conclusions: </strong>In summary, our study demonstrates that four immune-related proteins, including MICB, promote cerebral atherosclerosis by downregulating the ferroptosis-protective factor FTMT. Importantly, single-cell MR reveals that MICB acts as a risk factor for CeA specifically in NK cells and plasma cells, providing new mechanistic insight into cell-type-dependent immune regulation of vascular disease.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"18 1","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13700353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xuejiao Pu, Binyu Bai, Jing Yu, Kai Zhang, Ting Zhou, Biao Xie, Peng Wang, Dan Shi
{"title":"Accelerated biological aging mediates the associations of plasma lactate and the glucose-lactate index with MASLD: a prospective cohort study.","authors":"Xuejiao Pu, Binyu Bai, Jing Yu, Kai Zhang, Ting Zhou, Biao Xie, Peng Wang, Dan Shi","doi":"10.1186/s13148-026-02219-5","DOIUrl":"10.1186/s13148-026-02219-5","url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked to metabolic dysfunction. Lactate and the glucose-lactate index may reflect systemic glucose-lactate metabolic dysregulation, but their associations with MASLD and the potential mediating role of accelerated biological aging remain unclear.</p><p><strong>Methods: </strong>This cohort study included 175,612 UK Biobank participants. Plasma metabolites were quantified by nuclear magnetic resonance spectroscopy. Cox models assessed associations with incident MASLD, and mediation analyses evaluated PhenoAge acceleration (PhenoAge Accel), KDM-BA acceleration (KDM-BA Accel), and relative leukocyte telomere length (rLTL). Complementary transcriptomic analyses were conducted using GSE126848, and the co-expression of selected gene pairs was further assessed using the ChIPBase v3.0 Co-Expression tool.</p><p><strong>Results: </strong>Higher lactate and the glucose-lactate index were associated with increased MASLD risk (tertile 3 vs. 1 hazard ratios: 1.19 [95% CI, 1.07-1.32; P = 0.001] and 1.29 [95% CI, 1.16-1.43; P < 0.001], respectively). Both biomarkers were associated with higher PhenoAge Accel and KDM-BA Accel and lower rLTL. PhenoAge Accel mediated 32.3% and 20.8% of the respective associations, whereas KDM-BA Accel mediated 8.2% and 11.8%; rLTL mediation was not significant. Seven lactate metabolism-related genes and 20 representative aging-related genes were differentially expressed between healthy and MASLD liver tissues, and the corresponding transcriptional scores were positively correlated. Selected gene pairs also showed significant co-expression in the ChIPBase v3.0 Co-Expression analysis.</p><p><strong>Conclusion: </strong>Elevated lactate and the glucose-lactate index were associated with higher MASLD risk, with these associations partly mediated by accelerated biological aging. These findings provide prospective population-based and tissue-level evidence suggesting potential interrelationships among metabolic dysregulation, accelerated aging, and MASLD risk.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"18 1","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13700495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Simultaneous X-chromosome inactivation and tissue-/cell-type-specific DNA methylation in the transcriptional regulatory region of the X-linked recessive disease gene OTC.","authors":"Fuko Yamada, Shiori Hinata, Ryohei Shigeta, Hiroshi Nagashima, Kenji Yamatoya, Jun Ohgane","doi":"10.1186/s13148-026-02217-7","DOIUrl":"10.1186/s13148-026-02217-7","url":null,"abstract":"<p><strong>Background: </strong>Variability in disease onset and severity among heterozygous females with X-linked recessive disorders, such as ornithine transcarbamylase (OTC) deficiency, may result from differences in the expression level of the normal allele caused by skewed X-chromosome inactivation (XCI). However, previous studies on the mechanisms of XCI lack relevance to humans. By applying the concept of hypomethylated allele frequency, gene expression can be estimated through DNA methylation analysis of transcriptional regulatory regions, including tissue-/cell-type-specific differentially methylated regions (T-DMRs) and XCI-affected regions.</p><p><strong>Results: </strong>In this study, we identified a porcine OTC transcriptional regulatory region that functions both as a T-DMR and XCI-affected differentially methylated region. Furthermore, by distinguishing alleles using a single nucleotide polymorphism, we detected evidence of skewed XCI in female pigs.</p><p><strong>Conclusions: </strong>Accordingly, by demonstrating that hypomethylated allele frequency reflects the active X allele, this study provides possible molecular evidence of skewed X inactivation through DNA methylation within the OTC T-DMR.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"18 1","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13700207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sehrish Khan, Raed Said, Christopher Eskiw, François Thuot, Benoit Guay, Petros Papagerakis, Silvana Papagerakis
{"title":"Bridging the gap: advanced chromatin biotechnologies for circadian epigenomic profiling in head and neck squamous cell carcinoma.","authors":"Sehrish Khan, Raed Said, Christopher Eskiw, François Thuot, Benoit Guay, Petros Papagerakis, Silvana Papagerakis","doi":"10.1186/s13148-026-02189-8","DOIUrl":"10.1186/s13148-026-02189-8","url":null,"abstract":"<p><p>Surgery, radiotherapy and chemotherapy remain the main therapies for treating head and neck cancers, however new modalities have emerged with an emphasis to understand the complexity of the tumor biology. One emerging layer of complexity is the circadian clock, disrupted in many cancers, contributes to pathogenesis and progression due to its crosstalk with cancer pathways. While transcriptional alterations of core clock genes have been described in Head and Neck squamous cell carcinoma (HNSCC), the higher-order epigenetic and chromatin-based mechanisms underlying circadian dysregulation remain poorly defined. In this review, we highlight the potential of several chromatin-based biotechnologies in characterizing circadian clock disruption and identifying epigenetic biomarkers in HNSCC. Powerful assays including Chromatin conformation capture, Chromatin immunoprecipitation, DNA methylation profiling, ATAC-seq and single cell technologies can dissect circadian disruption at multiple regulatory layers. These approaches enable genome-wide mapping of chromatin accessibility, histone modifications, and 3D chromatin organization. Integrating these approaches across HPV-positive (HPV+) and HPV-negative (HPV-) HNSCC provides a framework to determine whether circadian disruption reflects transcriptional deregulation alone or involved structural genome remodeling that actively drives tumor progression. Linking circadian disruption to epigenomic reprogramming in HNSCCs can serve to identify mechanisms of therapeutic resistance and identify vulnerabilities. Advancing chromatin-informed circadian biomarker discovery in HNSCC has the potential to shift precision oncology from static genomic profiling toward dynamic, architecture-based epigenetic regulation.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"18 1","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13700348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Lactate-driven metabolic-epigenetic reprogramming in breast cancer: immune evasion and therapeutic resistance.","authors":"Lei Sun, Li Wang, Wanqin Zeng, Shiyan Zeng","doi":"10.1186/s13148-026-02216-8","DOIUrl":"10.1186/s13148-026-02216-8","url":null,"abstract":"<p><strong>Background: </strong>Breast cancer develops within a metabolically heterogeneous tumor microenvironment characterized by regional hypoxia, glycolytic activation, lactate accumulation, extracellular acidification, and impaired antitumor immunity. Lactate is now recognized not only as a metabolic end product, but also as a transported substrate, a receptor ligand, and a potential source of lysine lactylation.</p><p><strong>Main body: </strong>In this Review, we summarize current evidence on lactate production, MCT1/MCT4-dependent trafficking, GPR81/HCAR1-mediated sensing, immune remodeling, and metabolic-epigenetic regulation in breast cancer. We organize these effects into three interconnected layers. First, extracellular acidification, nutrient competition, and redox stress produce rapid and potentially reversible suppression of CD8⁺ T cells, natural killer cells, and dendritic cells. Second, sustained lactate-rich conditions alter the relative fitness of immune and stromal populations, weakening cytotoxic effectors while supporting regulatory T cells, tumor-associated macrophages, suppressive myeloid populations, and stromal immune exclusion. Third, histone and non-histone lactylation, together with RNA-level and chromatin regulatory mechanisms, may contribute to more durable state fixation. We distinguish direct breast cancer evidence from mechanisms established in other cancers and from transcriptome-based lactylation-associated signatures. We also discuss methodological limitations, subtype-specific evidence, and therapeutic strategies targeting lactate production, transport, sensing, and downstream epigenetic regulation.</p><p><strong>Short conclusion: </strong>Lactate-driven metabolic and epigenetic regulation provides a useful framework for understanding immune evasion and therapeutic resistance in breast cancer. However, direct mechanistic evidence remains concentrated in triple-negative breast cancer and tumor-intrinsic phenotypes. Lactylation should therefore be considered a candidate mechanism of durable state fixation rather than a universal explanation for lactate-associated effects. Future studies integrating direct lactylation measurements, spatial multi-omics, functional perturbation, and patient-derived models will be required to define clinically actionable lactate-dependent states.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"18 1","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149237142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jun Liu, Song Zhou, Jihong Zhang, Shuyu Ke, Junming Huang
{"title":"Stress, diet, and aging: a comprehensive analysis of allostatic load in biological aging.","authors":"Jun Liu, Song Zhou, Jihong Zhang, Shuyu Ke, Junming Huang","doi":"10.1186/s13148-026-02210-0","DOIUrl":"10.1186/s13148-026-02210-0","url":null,"abstract":"<p><strong>Background: </strong>As the global population continues to age, biological aging has emerged as a significant public health challenge. It is imperative to identify modifiable factors and underlying mechanisms that can promote healthy aging. Allostatic load (AL), a comprehensive indicator of chronic stress, is linked to numerous adverse outcomes in behavioral health. However, there is a paucity of comprehensive analyses and mechanistic investigations regarding the relationship between AL and biological aging across the entire population. This study seeks to elucidate the relationship between AL and biological aging, with a particular focus on examining the mediating role of the Dietary Inflammatory Index (DII).</p><p><strong>Method: </strong>This study analyzed data from NHANES (2001-2010 and 2015-2018) with 25,775 U.S. adults, excluding those with missing data. It measured AL using 8 biomarkers and assessed biological aging with four indicators: Phenotypic Age, Biological Age, GOLD BioAge, and Light BioAge. The DII was calculated from 24-h dietary recall of 45 food items. Sociodemographic and clinical factors were covariates. Weighted linear and logistic regressions examined the complex relationship between AL, DII, and biological aging, with subgroup and mediation analyses exploring mediating role of DII in the AL-aging link.</p><p><strong>Result: </strong>A total of 21.56% of participants were in the high AL group, showing significantly higher DII scores and elevated biological aging indicators compared to the low AL group (P < 0.001). After adjusting for confounders, high AL was linked to faster biological aging, with a 2.08-year increase in Phenotypic Age and a 9.06-year increase in Biological Age. Odds ratios for elevated GOLD BioAge and Light BioAge were 1.60 and 2.16, respectively (P < 0.001). The AL-aging link was stronger in young/middle-aged adults, females, and non-obese individuals. DII was positively linked to all aging indicators, and exploratory mediation analysis suggested that DII may statistically account for a small proportion of the AL-aging association, with mediation proportions ranging from 0.33% to 5.45% (P < 0.001).</p><p><strong>Conclusion: </strong>In a nationally representative sample of U.S. adults, elevated AL is significantly associated with accelerated biological aging assessed by multiple complementary indicators, and exploratory mediation analysis suggested that DII may partly account for part of this association. These findings underscore the importance of mitigating chronic physiological stress and reducing the inflammatory potential of the diet as strategies to promote healthy aging. Clinical assessment of AL and DII may provide valuable insights for identifying individuals at risk of accelerated biological aging and guiding targeted intervention measures to improve long-term health outcomes.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"18 1","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13681942/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Karine Badonnel, Aurélie Chaulot-Talmon, Valentin Costes, Anne Frambourg, Gabriel Costa-Monteiro-Moreira, Mélanie Jouin, Lorraine Bourgeois-Brunel, Anne Gabory, Hélène Kiefer, Hélène Jammes, Christine Baly
{"title":"Neuroepigenetic programming by the maternal environment: part A-epigenome-wide DNA methylation profile in the offspring's olfactory bulb following preconceptional weight loss in mice.","authors":"Karine Badonnel, Aurélie Chaulot-Talmon, Valentin Costes, Anne Frambourg, Gabriel Costa-Monteiro-Moreira, Mélanie Jouin, Lorraine Bourgeois-Brunel, Anne Gabory, Hélène Kiefer, Hélène Jammes, Christine Baly","doi":"10.1186/s13148-026-02167-0","DOIUrl":"10.1186/s13148-026-02167-0","url":null,"abstract":"<p><strong>Background: </strong>Experimental models and epidemiological data suggest that the maternal nutritional environment during gestation plays important roles in brain development with consequences on cognitive health. Epigenetic marks, such as methylation and histone modifications, are likely to be involved in this programming, but little addressed the impact of maternal metabolism at the preconceptional period. In mice, we recently demonstrated lasting effects of a maternal preconceptional weight loss on metabolic outcomes and behaviors related to food intake in the male offspring, exhibiting a reduction in olfactory sensitivity, along with a lack of fasting-induced olfactory-based motivation. To evaluate if this effect was driven by epigenetic modifications in the olfactory bulb, we profiled brain DNA methylation, a fundamental process in mediating the relation between early life environment and long-term behaviors in mice according to the maternal status.</p><p><strong>Results: </strong>Using oxidative reduced representation bisulfite sequencing to specifically target 5mC in mice exposed to preconceptional weight loss versus controls, we identified 11,055 differentially methylated cytosines and 150 differential methylated regions (DMRs) located in 111 genes in the olfactory bulb, a main region involved in odor processing and integration. Among the cytosines differentially methylated, half were hypermethylated. Methylation remodeling according to the maternal group preferentially affected noncoding intragenic regions, distal regulatory elements, and open sea CpGs, while promoter CpG islands remain relatively resistant to modification in DNA methylome. The functional annotation of DMRs pointed out genes related to histones kinases, energy signaling, synaptic function, and cellular differentiation, suggesting that targeted methylation changes may simultaneously influence epigenetic regulation, metabolism, and neurobiology.</p><p><strong>Conclusion: </strong>Thanks to a single-base analysis of differential methylated CpGs, we present novel evidence that the maternal dietary environment prior to conception exerts maternally-driven epigenetic effects, markedly altering 5-methylcytosine patterns in the adult offspring brain. This long-lasting remodeling of the offspring's olfactory bulb methylome may underlie the described alterations in olfactory-driven behaviors of offspring born to WL mother.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"18 1","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13681779/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"FUBP1 lactylation suppresses trophoblast function in fetal growth restriction.","authors":"Xinyue Liang, Shenshen Yao, Jian Ma, Dan Wang","doi":"10.1186/s13148-026-02208-8","DOIUrl":"10.1186/s13148-026-02208-8","url":null,"abstract":"<p><strong>Background: </strong>Fetal growth restriction (FGR) is a common complication of pregnancy; however, its exact molecular mechanisms remain unclear. Excessive lactate accumulation in the placenta is often observed during FGR. High concentrations of lactate can regulate the proliferation of pathological cells through lactylation of key proteins. Therefore, we aimed to screen key lactylation modification-related genes (LMRGs) and provide new directions for the diagnosis and treatment of FGR.</p><p><strong>Methods: </strong>The Differentially expressed LMRGs (DE-LMRGs) in FGR were evaluated using the Gene Expression Omnibus database. Functional enrichment analysis was performed, and a protein-protein interaction (PPI) network was created to explore the characteristics of placental gene networks associated with FGR. In addition, secondary cluster analysis was performed using a machine learning algorithm to screen critical genes. We evaluated the degree of immune cell infiltration of key genes using single-sample gene set enrichment analysis. The expression and function of key genes in FGR were verified experimentally. Furthermore, FUBP1 lactylation was assessed using mass spectrometry and immunoprecipitation. We overexpressed wild-type and mutant FUBP1 in HTR-8/SVneo cells to investigate how its lactylation regulates trophoblast function. Finally, patient-derived organoids (PDO) were cultured to confirm the underlying mechanism of FUBP1.</p><p><strong>Results: </strong>In total, 35 DE-LMRGs were identified, and their PPI network was constructed. Two distinct FGR clusters were obtained using unsupervised consensus clustering. Moreover, the DE-LMRGs between the two patterns were mainly enriched in immune cell regulation-related molecular functions. We identified 5 overlapping key genes (BCLAF1, FUBP1, S100A6, CSRP1, CSRP2) by integrating the LASSO, random forest (RF), and SVM-RFE algorithms and screening for genes with a large fold change (using log2-FC). FUBP1 and BCLAF1 expression was lower in FGR placental tissues than in normal controls. Functional assays showed that both genes typically promote HTR-8/SVneo cell proliferation and invasion. However, lactylation of FUBP1 exerted the opposite effect by inhibiting proliferation and invasion and promoting apoptosis, indicating that FUBP1 lactylation regulates trophoblast function. Furthermore, PDO derived from the trophoblast tissues of patients with FGR revealed that FUBP1 lactylation suppressed PDO formation.</p><p><strong>Conclusions: </strong>FUBP1 lactylation is identified as a novel mechanism suppressing trophoblast function in FGR. This finding expands the field of FGR research by highlighting the role of lactylation-modified proteins and provides crucial insights into the pathological mechanisms of FGR.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"18 1","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13681806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Haoqian Zhang, Dandan Shen, Nanshan Lin, Li Yang, Chenchen Ren
{"title":"New perspective on epigenetic modification and immunotherapy in endometrial cancer.","authors":"Haoqian Zhang, Dandan Shen, Nanshan Lin, Li Yang, Chenchen Ren","doi":"10.1186/s13148-026-02174-1","DOIUrl":"10.1186/s13148-026-02174-1","url":null,"abstract":"<p><p>Endometrial carcinoma (EC) is a heterogeneous gynecological malignancy. Epigenetic dysregulation promotes the initiation, progression, immune evasion, and therapeutic resistance of EC. Aberrant DNA methylation, histone methylation, histone acetylation, and chromatin remodeling affect key EC-associated pathways and help shape distinct molecular subtypes, including POLE-mutated and mismatch repair-deficient tumours. In this review, we summarize the major epigenetic alterations implicated in EC, with emphasis on DNA methylation regulators, histone-modifying enzymes, and emerging epigenetic targets such as DNMTs, HDACs, LSD1, EZH2, PRMTs, and BET proteins. We further highlight the rapidly evolving immunotherapy landscape in EC, including clinically established or practice-changing regimens such as pembrolizumab-, dostarlimab-, durvalumab-, and lenvatinib-based strategies, particularly in advanced or recurrent disease. In parallel, we discuss investigational epigenetic therapies, including DNMT inhibitors, HDAC inhibitors, LSD1 inhibitors, EZH2-targeted agents, PRMT inhibitors, and BRD4-directed approaches, which are being explored to restore tumour suppressor pathways, enhance tumour immunogenicity, and improve sensitivity to immune checkpoint blockade. By integrating EC-specific epigenetic mechanisms with current immunotherapy advances and ongoing combination strategies, this review provides a clinically oriented perspective on biomarker-guided precision treatment for EC.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":"18 1","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13678994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149220083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dorian Pamart, Brieuc Cuvelier, Adrien Govaerts, Muriel Chapelier, Marielle Herzog, Andrew Retter, Thomas Bygott, Jean-Valery Turatsinze, Benjamin P Berman, Jacob Micallef
{"title":"Direct analysis of transcription factor protected cfDNA in plasma by ChIP-seq: measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy.","authors":"Dorian Pamart, Brieuc Cuvelier, Adrien Govaerts, Muriel Chapelier, Marielle Herzog, Andrew Retter, Thomas Bygott, Jean-Valery Turatsinze, Benjamin P Berman, Jacob Micallef","doi":"10.1186/s13148-026-02205-x","DOIUrl":"10.1186/s13148-026-02205-x","url":null,"abstract":"<p><strong>Background: </strong>The aggregate presence of cell free CTCF-DNA (cfCTCF-DNA) nucleoproteins in plasma has been reported. But the occupancy of individual CTCF binding sites in plasma cfCTCF-DNA has not been studied.</p><p><strong>Results: </strong>For the first time, we have isolated endogenous plasma cfCTCF-DNA by chromatin immunoprecipitation (ChIP) and sequenced the associated cfDNA (ChIP-Seq) in samples from cancer patients and healthy subjects. The mean observed enrichment of plasma cfCTCF-DNA by ChIP was 180-fold with a mean CTCF recovery of 48%. Background cfDNA, primarily in the form of nucleosomes, was almost completely physically removed (> 99.7%) by ChIP and the remainder was removed bioinformatically. cfCTCF-DNA sequences were partitioned into low or high affinity binding cfCTCF-DNA nucleoproteins in silico, on the basis of binding motif concordance with the consensus CTCF binding motif. We observed that cfCTCF-DNA was quantitatively and qualitatively different in samples from healthy subjects or cancer patients. High affinity cfCTCF-DNA nucleoproteins were present only in the plasma of cancer patients and not in samples from healthy subjects. Testing of small developmental and validation sample cohorts for ChIP-seq peaks for a 14 member panel of high affinity CTCF loci sequences, showed excellent specificity and sensitivity for cancer detection.</p><p><strong>Conclusions: </strong>Plasma sequence data sets comprising > 99% pure CTCF protected ctDNA can be prepared using a 2-step process involving the physical removal of most background cfDNA in vitro, followed by removal of all remaining background cfDNA in silico. CTCF plasma ChIP-seq represents a novel liquid biopsy method for a novel class of liquid biopsy biomarkers.</p>","PeriodicalId":10366,"journal":{"name":"Clinical Epigenetics","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13670819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148548075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}